152 related articles for article (PubMed ID: 6113673)
1. [Diagnostic importance of blood histamine levels in myeloproliferative diseases].
Gingold N
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):541-6. PubMed ID: 6113673
[No Abstract] [Full Text] [Related]
2. [The histaminemia in the diagnosis of chronic myeloid leukemia].
Gingold N
Nouv Rev Fr Hematol; 1968; 8(3):386-9. PubMed ID: 4234497
[No Abstract] [Full Text] [Related]
3. [Blood histamine level in chronic myeloproliferative diseases; a review].
Gingold N
Onkologie; 1979 Apr; 2(2):70-4. PubMed ID: 392372
[TBL] [Abstract][Full Text] [Related]
4. [Differential diagnosis of eosinophilia in combination with intoxication syndrome].
Egorov IV; Kotina LN
Klin Med (Mosk); 2004; 82(8):70-2. PubMed ID: 15468731
[No Abstract] [Full Text] [Related]
5. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.
Abukhiran IA; Jasser J; Syrbu S
J Clin Pathol; 2020 Jun; 73(6):310-313. PubMed ID: 31941653
[TBL] [Abstract][Full Text] [Related]
6. [The blood histamine level in differential and early diagnosis of chronic myelocytic leukemia].
Gingold N
Wien Z Inn Med; 1968; 49(5):180-6. PubMed ID: 5261000
[No Abstract] [Full Text] [Related]
7. [A "myeloproliferative syndrome" of long duration (author's transl)].
Kühböck J; Peskar BM; Vormittag W
Med Klin; 1974 Mar; 69(10):423-6. PubMed ID: 4524608
[No Abstract] [Full Text] [Related]
8. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnostic significance of the Ph chromosome].
Hampel KE
Verh Dtsch Ges Inn Med; 1967; 73():457-60. PubMed ID: 5242223
[No Abstract] [Full Text] [Related]
10. Disseminated hepatosplenic mycobacterial infection masking myeloproliferative diseases as leukemoid reaction: a diagnostic pitfall.
Au WY; Ma SK; Kwong YL
Leuk Lymphoma; 2001 Aug; 42(4):805-8. PubMed ID: 11697512
[TBL] [Abstract][Full Text] [Related]
11. [Atypical and controversial forms of chronic myeloid leukemia].
Rodríguez Fernández JM; Martiń de Segovia JM
Sangre (Barc); 1984; 29(4-B):629-44. PubMed ID: 6393386
[No Abstract] [Full Text] [Related]
12. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
Haferlach T; Kern W; Schnittger S; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
[TBL] [Abstract][Full Text] [Related]
13. Leukemia or leukemoid, Down syndrome or not?
Ho MH; Ha SY; Chan GC; Ma ES
Haematologica; 2004 Sep; 89(9):ECR33. PubMed ID: 15377485
[No Abstract] [Full Text] [Related]
14. Differential leucocyte alkaline phosphatase activity (LAPA) in chronic myeloid leukaemia (CML) and myeloid leukemoid reaction (MLR).
Zafar MN; Navid-ul-Haq ; Qureshi SJ; Qureshi H
J Pak Med Assoc; 1984 May; 34(5):114-6. PubMed ID: 6429381
[No Abstract] [Full Text] [Related]
15. Increased transcobalamin I in a leukemoid reaction.
Hall CA; Wanko M
J Lab Clin Med; 1971 Aug; 78(2):298-301. PubMed ID: 5284678
[No Abstract] [Full Text] [Related]
16. Comments on feline leukemia: clinical and pathologic features, differential diagnosis.
Schalm OW
J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1025+. PubMed ID: 5280564
[No Abstract] [Full Text] [Related]
17. [Critical study of the concept of the myeloproliferative syndrome (author's transl)].
Najean Y
Nouv Presse Med; 1977 Oct; 6(35):3179-83. PubMed ID: 270652
[No Abstract] [Full Text] [Related]
18. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
[No Abstract] [Full Text] [Related]
19. Nonleukemic elevation of serum vitamin B 12 and B 12 -binding capacity levels resembling that in chronic myelogenous leukemia.
Carmel R; Coltman CA
J Lab Clin Med; 1971 Aug; 78(2):289-97. PubMed ID: 4105424
[No Abstract] [Full Text] [Related]
20. Myeloproliferative disorders: III. CML: Further studies on the role of cytogenetics in diagnosis, prognosis and management.
Fuscaldo KE; Brodsky I; Kahn SB; Conroy JF; Marfurt K
Haematologica; 1981 Aug; 66(4):461-88. PubMed ID: 6797881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
